Table 2.
KAN | TOB | GEN | TCY | MNO | ERY | LIN | PRI | CIP | SXT | RIF |
S | S | S | R | S | R | R | S | S | R | S |
S | S | S | R | R | R | R | S | S | S | S |
R | S | S | R | S | R | R | S | R | R | S |
R | R | R | R | R | S | S | S | S | R | S |
S | S | S | R | R | R | R | R | R | R | I |
R | R | R | R | R | R | S | S | S | R | S |
S | S | S | R | S | S | S | S | R | S | R |
R | R | R | R | R | R | R | R | R | R | I |
KAN: kanamycin, TOB: tobramycin, GEN: gentamycin, TCY: tetracycline, MNO:minocyclin, ERY: erythromycin, LIN: lincomycin, PRI: pristiniamycin, CIP: ciprofloxacin, SXT: Trimethoprim-sulfamethoxazole, RIF: rifampycin